Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
TipRanks on MSN
Cocrystal Pharma reports Q3 EPS (19c) vs (49c) last year
We expect to begin enrolling participants in the first quarter of 2026 for our norovirus challenge study evaluating CDI-988, our oral ...
Norovirus causes vomiting and diarrhoea. While it's unpleasant, it typically clears up in about two days, according to NHS ...
Norovirus triggers symptoms such as vomiting and diarrhoea. While it can be extremely unpleasant, it typically resolves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback